Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 3,741,627 $ 6,970,926
Accounts receivable, net of allowance 182,464 5,692,479
Prepaids 81,459 699,150
Other assets 69,235 254,454
Assets held for sale 25,030,359 79,050,532
Total current assets 29,105,144 92,667,541
Property, plant and equipment, net 2,050,000 11,001,273
Total assets 31,155,144 103,668,814
Current liabilities:    
Accounts payable 15,181,502 11,828,201
Accrued expenses 3,760,135 1,606,922
Short-term notes payable 7,916,188
Liabilities held for sale 7,703,411 17,552,929
Total current liabilities 34,561,236 30,988,052
Commitments and contingencies
Stockholders' equity (deficit)    
Preferred stock, $0.001 par value, 50,000,000 shares authorized, 30,000 designated as Series A Convertible Preferred Stock, 10,600 of Series A Preferred issued and outstanding at December 31, 2018 and none issued or outstanding at December 31, 2017 11
Common stock, $0.001 par value, 200,000,000 shares authorized, 18,849,935 issued and 18,844,472 outstanding at December 31, 2018 and 18,649,937 issued and 18,644,474 outstanding at December 31, 2017 75,400 74,578
Additional paid-in capital 155,850,502 144,071,119
Treasury stock, at cost; 5,462 common shares at December 31, 2018 and December 31, 2017 (57,469) (57,469)
Accumulated deficit (159,274,536) (71,407,466)
Total stockholders' equity (deficit) (3,406,092) 72,680,762
Total liabilities and stockholders' equity (deficit) $ 31,155,144 $ 103,668,814